In vivo deposition study of a new generation nebuliser utilising hybrid resonant acoustic (HYDRA) technology.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2020.119196
Abstract: Conventional nebulisation has the disadvantages of low aerosol output rate and potential damage to macromolecules due to high shear (jet nebulisation) or cavitation (ultrasonic nebulisation). HYDRA (HYbriD Resonant Acoustics) technology has been shown to overcome… read more here.
Keywords: vivo deposition; deposition study; deposition; hydra ... See more keywords